Sort
25,944 grants matching “neurodegeneration”
Preventing and Reversing Mitochondrial Leigh Syndrome with Hypoxia
$481,230Vamsi Krishna Mootha · Massachusetts General Hospital · R01 · FY2024 · NS
Mechanisms of mitochondrial disease suppression in Ndufs4 knockout mice
$481,224Matt Kaeberlein · University Of Washington · R01 · FY2018 · NS
Understanding Selectivity Mechanisms of Network Vulnerability and Resilience in Alzheimer's Disease by Establishing a Neurobiological Basis through Network Neuroscience
$481,086Guorong Wu · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AG
Bone marrow derived neural stem cell therapy for glioma
$481,079John S Yu · Cedars-Sinai Medical Center · R01 · FY2006 · NS
Mechanisms of Huntingtin Induced Neurodegeneration
$481,065J. David Gladstone Institutes · R01 · FY2005 · NS
Development of Immunological Reagents for the Identification of New World Monkey Biomarkers
$481,017Luis David Giavedoni · Trinity University · R24 · FY2022 · OD
Cognitive Assessment and Adjudication Core
$480,918Terry Goldberg · Columbia University Health Sciences · U19 · FY2022 · AG
Mechanistic insights into the link between the A152T risk variant and tauopathy
$480,752Casey N Cook · Mayo Clinic Jacksonville · R01 · FY2021 · AG
High Performance Computer System for Biomolecular and Systems Modeling
$480,726Jason Robert Banfelder · Weill Medical Coll Of Cornell Univ · S10 · FY2010 · RR
Aging and Dementia in Down Syndrome: Connectivity, Inflammation, and Cerebrovascular Contributions
$480,720Elizabeth Head · University Of Kentucky · R01 · FY2015 · HD
Investigating a novel vascular pathway that regulates neuronal survival
$480,710Shanthini Sockanathan · Johns Hopkins University · R01 · FY2025 · AG
The Nigral Molecular Clock and Vulnerability to Neurodegeneration
$480,689Karen L Gamble · University Of Alabama At Birmingham · R01 · FY2018 · NS
The autophagy lysosomal pathway: regulation by progranulin and its role in neurodegenerative disease
$480,683Steven M Finkbeiner · Northwestern University · P01 · FY2020 · AG
SCA7 neurodegeneration: molecular epigenetic basis and therapy development
$480,628Albert R La Spada · University Of California, San Diego · R01 · FY2015 · EY
Targeting the ANG/TIE2 pathway to treat Alzheimer's disease and related dementias
$480,536Gareth R Howell · Jackson Laboratory · R21 · FY2023 · AG
SCA7 neurodegeneration: molecular epigenetic basis and therapy development
$480,489Albert R La Spada · University Of California, San Diego · R01 · FY2014 · EY
E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma
$480,477Pawan Sharma · Temple Univ Of The Commonwealth · R01 · FY2025 · HL
Training in the Neurobiology of Aging and Alzheimer's Disease
$480,366Andrea Joan Tenner · University Of California-Irvine · T32 · FY2022 · AG
Neural circuit mechanisms underlying AD-related memory impairments
$480,320Xiangmin Xu · University Of California-Irvine · R01 · FY2024 · AG
Blood Biomarkers as Surrogate Endpoints of Treatment Responses to Aerobic Exercise and/or Cognitive Training in Amnestic Mild Cognitive Impairment
$480,197Danni Li · University Of Minnesota · R01 · FY2021 · AG
Mitochondria: controllers of trauma-induced secondary neurodegeneration onset
$480,156Tonia S Rex · Vanderbilt University Medical Center · R01 · FY2025 · EY
The role of activity induced exosome signaling in synaptic pathology of Alzheimer's Disease
$480,031Jeffrey Nicholas Savas · Northwestern University At Chicago · R01 · FY2019 · AG
Expanding the set of genetically encoded tools for compartment-specific manipulation of redox metabolism in living cells
$480,000Valentin Cracan · Scintillon Institute For Photobiology · R35 · FY2024 · GM
Expanding the set of genetically encoded tools for compartment-specific manipulation of redox metabolism in living cells
$480,000Valentin Cracan · Scintillon Institute For Photobiology · R35 · FY2022 · GM
Expanding the set of genetically encoded tools for compartment-specific manipulation of redox metabolism in living cells
$480,000Valentin Cracan · Scintillon Institute For Photobiology · R35 · FY2025 · GM